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Abstract The cellular sites of insulin-like growth factor I
(IGF-I) synthesis in the early developing tilapia (0-140
days post fertilization, DPF) were investigated. IGF-I
mRNA and peptide appeared in liver as early as 4 DPF and
in gastro-intestinal epithelial cells between 5-9 DPF. In
exocrine pancreas, the expression of IGF-I started at 4 DPF
and continued until 90 DPF. IGF-I production was detected
in islets at 6 DPF in non-insulin cells and occurred
throughout life. In renal tubules and ducts, IGF-I produc-
tion started at 8 DPF. IGF-I production in chondrocytes had
its onset at 4 DPF, was more pronounced in growing
regions and was also found in adults. IGF-I mRNA and
peptide appeared in the cytoplasm of skeletal muscle cells
at 4 DPF. In gill chloride cells, IGF-I production started at 6
DPF. At 13 DPF, IGF-I was detected in cardiac myocytes.
IGF-I-producing epidermal cells appeared at 5 DPF. In
brain and ganglia, IGF-I was expressed in virtually all
neurones from 6 to 29 DPF, their number decreasing with
age. Neurosecretory IGF-I-immunoreactive axons were
first seen in the neurohypophysis around 17 DPF. Endo-
crine cells of the adenohypophysis exhibited IGF-I mRNA
at 28 DPF and IGF-I immunoreactivity at 40 DPF. Thus,
IGF-I appeared early (4-5 DPF), first in liver, the main
source of endocrine IGF-I, and then in organs involved in
growth or metabolism. The expression of IGF-I was more
pronounced during development than in juvenile and adult
life. Local IGF-I therefore seems to have a high functional
impact in early growth, metabolism and organogenesis.
Keywords Liver . Gastro-intestinal tract . Pancreas .
Kidney . Muscle . Brain . Pituitary . Gills . Heart .
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Introduction
Autocrine, paracrine and endocrine signals co-ordinate the
direction of differentiation of tissues during critical periods
of development. The differentiation of organs thus involves
a complex cascade and interaction of signals whose
organizational action on tissue differentiation is dependent
on being released at precise times, at correct sites (in the
case of para- and autocrine factors) and within a specific
dose range (Segner et al. 1994). Insulin-like growth factor I
(IGF-I) plays a central role in the complex system that
regulates growth, differentiation and reproduction (see
review: Reinecke and Collet 1998).
As in mammals, the major site of IGF-I gene expression
in bony fish is liver but several extrahepatic sites also
express IGF-I (for reviews, see Reinecke and Collet 1998;
Duan 1998; Reinecke et al. 2005; Wood et al. 2005).
Recently, by the use of real-time reverse transcription/
polymerase chain reaction (RT-PCR), the absolute amounts
of IGF-I have been measured in adult tilapia, Oreochromis
niloticus (Caelers et al. 2004), and significant levels of
IGF-I mRNA have been measured not only in liver, but
also in other organs, such as brain, gills, heart, intestine,
kidney, skeletal muscle, spleen and testes. These results are
consistent with the earlier immunohistochemical identifi-
cation of parenchymal cells as local production sites in
numerous organs of tilapia (Reinecke et al. 1997) and
indicate paracrine/autocrine actions of local IGF-I involved
in organ-specific functions of adult bony fish.
Some studies in bony fish showing the presence of IGF-I
and its receptor (IGF-1R) in fish embryos suggest a high
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organizational impact of IGF-I during ontogeny. Develop-
mental and tissue-specific regulation of the steady-state
mRNA levels of IGF-1R and polyadenylation have been
detected in rainbow trout (Greene and Chen 1999) and
seabream (Perrot et al. 1999). Correspondingly, some RT-
PCR studies on trout (Shamblott and Chen 1993; Duan et
al. 1995; Greene and Chen 1997, 1999), seabream (Duguay
et al. 1996; Perrot et al. 1999) and rabbitfish (Ayson et
al. 2002) suggest that the expression patterns of IGF-I
mRNA in several organs are also age-dependent. The
physiological importance of IGF-I in early fish develop-
ment is further underlined by the demonstration of the
marked mitogenic effects of IGF-I on zebrafish embryonic
cells (Pozios et al. 2001).
However, little information exists regarding the cellular
sites of IGF-I synthesis, with only two studies in seabream
(Perrot et al. 1999) and rabbitfish (Radaelli et al. 2003) and
some preliminary data in tilapia (Shved et al. 2005)
reporting the localization of IGF-I during ontogeny. These
reports involve the investigation of several organs at
different larval stages by the use of immunohistochemistry.
However, no thorough study on the cellular IGF-I
production during early fish development has been
performed and no other species have been examined.
Furthermore, to date, in situ hybridization has not been
used to detect the cellular expression of IGF-I mRNA
during ontogeny. Therefore, we have investigated the
potential production sites of IGF-I in numerous organs,
such as liver, gastro-intestinal tract, exo- and endocrine
pancreas, kidney, skeletal muscle, cartilage, gills, skin,
brain and pituitary, in early developmental stages, i.e. from
0 day post fertilization (DPF) to 140 DPF, of tilapia
(Oreochromis niloticus) and in adult individuals. We have
used immunohistochemistry to localize IGF-I peptide and
in situ hybridization to detect the expression of IGF-I
mRNA.
Materials and methods
Animals
The fry and adult Oreochromis niloticus used in this study
originated from the Aquaculture Experimental Facilities of
CIRAD (Montpellier). Fertilized eggs were obtained
through either natural or artificial fertilization. For natural
fertilization, 0. niloticus breeders (1 male and 3 females)
were maintained in a spawning aquarium of 360 l
maintained at constant temperature (27°C) and photoperiod
(12L:12D). Under natural photoperiods, reproductive ac-
tivity occurs mainly from the afternoon until sunset in these
species (Baroiller et al. 1997). Consequently, we checked
every morning for the presence of newly incubating
females, which were then isolated from the other fish. On
the first day after fertilization, eggs were gently removed
from the mouth of the female and incubated in 1-l
McDonald jars at 27±1°C (mean range). For artificial
fertilization, the maturation of isolated females was
carefully recorded (i.e. uro-genital papilla development
and behaviour). When the near-breeding stage was
reached, both male and female breeders were striped
under anaesthesia. Fertilization was performed according
to Chourrout and Itskovitch (1983). After fertilization, eggs
were incubated in 1-l McDonald jars, maintained at 27°C,
to the free-swimming stage (around 10 DPF). Just before
the completion of yolk sac absorption, fry were placed into
a 50-l tank in an indoor recirculating system at 27±1°C.
They were fed with commercial salmonid food.
Fish larvae at various developmental stages, i.e. from
0-140 DPF, and adults were sampled and anaesthetized
by the addition of 2-phenoxy-ethanol (Sigma, St. Louis,
Mo., USA) to water (0.3 ml/l). For the earliest stages, the
trunk was cut to allow fixation solution to enter. If the
larvae had reached a sufficient size, the organs were
excised. Tissue preparations were fixed with Bouin’s
solution without acetic acid for 4 h at room temperature.
Specimens were dehydrated in an ascending series of
ethanol and routinely embedded in Paraplast (58°C).
Generation of tilapia-specific probes for in situ
hybridization
The probes used were prepared as previously described
(Schmid et al. 1999). In brief, total RNA from tilapia liver
was extracted by the phenol/chloroform method with an
Ultraspec Extraction Kit (ams, Lugano, Switzerland). For
cDNA synthesis, 5 μg RNAwere annealed with 1 μM poly
(dT) primer (5′-CC TGAATTCTAGAGCTCAT(dT17)-3′)
for 3 min at 70°C. The RNA/primer mix was incubated for
1 h at 37°C with 15 mM dNTPs and 10 U AMV-reverse
transcriptase (Pharmacia, Switzerland) in 1× reaction
buffer (50 mM TRIS-HCl pH 8.3, 40 mM KCl, 6 mM
MgCl2). A 1-μl cDNA aliquot was incubated with 1 μM of
the sense (5′-GTCTGTGGAGAGCGAGGCTTT-3′) and
antisense primer (5′-AACCTTGGGTGCTCTTGGCATG-
3′), corresponding to the B- and E- domains (Reinecke et
al. 1997), 200 μM dNTPs, and 1 U Taq-polymerase
(Pharmacia) in 1× incubation buffer (10 mM TRIS-HCl pH
8, 50 mM KCl, 1.5 mM MgCl2, 0.001% gelatine). The
amplification program was optimized for a Stratagene
RoboCycler Gradient 40 as follows: one cycle of 10 min at
94°C, 1 min at 59°C, 2 min at 72°C; 30 cycles of 1 min at
94°C, 1 min at 59°C and 2 min at 72°C followed by a final
extension step of 5 min at 72°C. PCR fragments were
separated on a 2% agarose gel and eluted by Gel Extraction
Kit QIAquick (Qiagen, Switzerland). PCR products were
cloned in a pCR-Script SK(+) cloning vector (Stratagene,
Heidelberg, Germany). After propagation of Escherichia
coli containing the plasmids, purification of the plasmids
was performed with the Midi Purification Kit (Qiagen).
Plasmids with the IGF-I fragment were sequenced (Micro-
synth, Switzerland) and the sequences were compared with
those in a database. The plasmids containing the specific
inserts of IGF-I (207 bp) were used as templates for the
synthesis of the digoxigenin (DIG)-labelled RNA probes.
Linearization was performed with the restriction enzyme
EcoRI for T3 polymerase-driven transcription and with
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NotI for T7 polymerase-driven transcription. After ethanol
precipitation, linearization efficiency was assured on a
1.2% agarose gel. The linearized plasmids (1 μg) were
transcribed in vitro by using a transcription kit (Roche
Diagnostics, Germany) in the presence of DIG-UTP to
obtain the antisense and sense probes. The IGF-I probes
selectively detected tilapia IGF-I and not tilapia IGF-II, as
shown previously (Schmid et al. 1999). The integrity of the
probes and the efficiency of the labelling were confirmed
by gel electrophoresis, including blotting and incubation
with antibody (Ab), and by dot blot. For dot blot, 1 μl
various dilutions (undiluted, 1:10, 1:100, 1:1,000) of
probes and control RNAs were dropped onto a nylon
membrane (Roche Diagnostics) and fixed by UV cross-
linking (254 nm, 125 mJ). The membrane was washed with
1% blocking reagent (Roche-Diagnostics) in buffer P1 for
30 min followed by treatment with alkaline phosphatase
(AP)-coupled anti-DIG Ab (Roche Diagnostics) diluted at
1:2,000 with 1% blocking reagent in P1 for 30 min. After a
rinse with P1, the membrane was equilibrated with buffer
P3 and finally washed with 1:50 diluted nitroblue tetrazo-
lium/5-bromo-4-chloro-3-indolyl-phosphate (NBT/BCIP)
stock solution (Roche Diagnostics) until colour develop-
ment. For gel electrophoresis and blotting, probes (200 ng)
were loaded onto a 1% denaturing formaldehyde agarose
gel in 1× MOPS and run at 80 V for 1.5 h. After the run, gel
and membrane were shaken in diethylpyrocarbonate
(DEPC)-H20 for 5 min. Capillary transfer was carried out
with 20× standard sodium citrate (SSC) overnight. Nucleic
acids were fixed by UV-crosslinking. Subsequently, the
membrane was incubated with the AP-labelled anti-DIG
Ab by applying the same procedure as for dot blot. Lengths
of the probes were compared with control RNA (760 nt,
Roche Diagnostics).
In situ hybridization protocol
Sections (4 μm thick) were mounted on Super Frost Plus
slides (Menzel-Gläser, Germany) and dried overnight at
42°C. After being dewaxed and rehydrated, the sections
were fixed with 4% paraformaldehyde and 0.1% glutaral-
dehyde in 1× phosphate-buffered saline (PBS). The
following steps were carried out with DEPC-treated
solutions in a humified chamber. The sections were
digested with 0.02% proteinase K in 20 mM TRIS-HCl
Table 1 Semiquantitative grading of the number of parenchymal cells demonstrated by IGF-I in situ hybridization (ISH) and IGF-I
immunohistochemistry (IHC)
Organ DPF
4–5
DPF
6–7
DPF
8–12
DPF
13–18
DPF
19–29
DPF
30–50
DPF
51–70
DPF
71–90
DPF
91–140
Adult
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Brain
Neurones - - + + ++ ++ +++ +++ +++ +++ + + + +/- + +/- + +/- + +/-
Meninges + + + + + + + + + +/- + +/- +/- +/- +/- +/- +/- +/- +/- +/-
Pituitary
anterior - - - - - - - - ++ - +++ +++ +++ +++ ++ ++ ++ ++ ++ ++
posterior - - - - - - - ++ - ++ - + - +/- - +/- - +/- - +/-
G-I tract
Stomach - - - - ++ ++ ++++ ++++ ++++ ++++ +++ +++ ++ ++ +/- +/- +/- +/- +/- +/-
Intestine ++++ ++++ ++++ ++++ +++ ++++ ++++ ++++ ++++ ++++ ++ ++ + + +/- +/- +/- +/- +/- +/-
Liver ++ - ++ + +++ + +++ + +++ ++ +++ ++ +++ + +++ +/- +++ - +++ -
Pancreas
exocrine + + ++ ++ ++ ++ ++ ++ + +/- +/- +/- +/- +/- +/- +/- - - - -
endocrine - - + + + + + + ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
Gills - - +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++
Kidney - - - - ++ ++ +++ +++ ++ ++ ++ ++ ++ ++ + + + + + +
Heart - - - - - - + + +++ + ++ + + + + + - - - -
Cartilage
Chondrocytes ++ + +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ ++ ++ + + + +
Perichondrium + + ++ ++ ++ ++ ++ ++ ++ ++ + ++ + + + + + + + +
Muscle + + ++ ++ +++ +++ +++ +++ ++++ ++++ ++ ++ ++ ++ ++ ++ + + + +
Epidermis + + + + + + ++ ++ +++ +++ + + + + +/- +/- +/- +/- +/- +/-
- none, +/- very few, + some, ++ moderate, +++ majority, ++++ overall
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pH 7.4, 2 mM CaCl2 for 10 min at 37°, treated with 1.5%
triethanolamine and 0.25% acetic anhydride for 10 min at
room temperature and incubated with 50 μl prehybridiza-
tion solution per section for 3-4 h at 54°C. Hybridization
was carried out overnight at 54°C with 30 μl of hybrid-
ization buffer containing 10 ng sense or antisense probe
previously denaturated for 5 min at 85°C. Slides were
washed for 15 min at room temperature in 2× SSC and for
30 min at the specific hybridization temperature at
descending concentrations of SSC (2×, 1×, 0,5×, 0,2×).
The anti-DIG AP-coupled Ab was diluted 1:4,000 in 1%
blocking reagent (Roche-Diagnostics) in buffer P1 and
applied to the sections for 1 h at room temperature in the
dark. After being washed twice in P1 for 15 min, the
sections were treated with buffer P3, 5 mM levamisole and
NBT/BCIP stock solution (Roche Diagnostics). Colour
development was carried out overnight at room tempera-
ture and stopped by rinsing in tap water for 15 min.
Immunohistochemistry
Sections were cut at 4 μm, mounted onto glass slides
(Menzel-Gläser) and dried overnight at 42°C. After being
dewaxed and rehydrated, they were used for immunohis-
tochemistry. To reduce unspecific binding, sections were
treated with PBS (pH 7.4) containing 2% bovine serum
albumin for 30 min at room temperature. Thereafter, the
sections were incubated overnight with rabbit antiserum
116 raised against human IGF-I (Reinecke et al. 1997;
Schmid et al. 1999) diluted at 1:400 and washed
repetitively in PBS. The IGF-I antiserum was detected by
incubation with biotinylated goat anti-rabbit IgG (Bio-
science Products, Emmenbrücke, Switzerland; 1:100) for
30 min at room temperature. After repetitive rinses in PBS,
the sections were incubated with streptavidin-fluorescein-
isothiocyanate (Bioscience Products; 1:100) for 30 min at
room temperature in the dark. The specificity of the
reactions obtained was tested by using the following
controls: (1) replacement of the primary antiserum by non-
immune rabbit serum, (2) pre-absorption of the primary
antiserum with recombinant human (h) IGF-I, hIGF-II,
porcine insulin (kind gift of Prof. J. Zapf, Zürich) or the
peptide used for immunization (40 μg or 400 μg peptide/ml
diluted antiserum). Photomicroscopy was performed with a
Zeiss Axioscope and Axiovision software 3.1. (Zeiss,
Zürich, Switzerland).
Results
General
During early development, IGF-I mRNA and peptide were
observed in all organs investigated. However, the onset of
IGF-I expression and its duration differed considerably
among the various tissues and organs (Table 1).
Fig. 1 IGF-I immunoreactivity (a, c) andmRNA (b, d) in developing
tilapia liver. a,b At 12 DPF, many hepatocytes exhibit IGF-I
immunoreactivity (a, white arrows) and IGF-I mRNA (b, black
arrows). Numerous mucosal epithelial cells of the intestine (I) contain
IGF-I mRNA (b). Bar 20 μm. c, d Tilapia liver at 36 DPF. IGF-I
immunoreactivity of variable intensity (c, white arrows) and mRNA
(d, black arrows) occur in numerous hepatocytes (V vein). Bars
30 μm
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Liver
At 4 DPF, several hepatocytes started to exbibit IGF-I
mRNA followed by IGF-I immunoreactivity around 6-7
DPF (Table 1). By 12 DPF, numerous hepatocytes showed
IGF-I mRNA and some also contained IGF-I peptide
(Fig. 1a,b). Around 36 DPF, a larger number of hepatocytes
contained IGF-I mRNA (Fig. 1d) and about half of the
hepatocytes also possessed IGF-I immunoreactivity at
variable intensity (Fig. 1c). Whereas the expression of IGF-
I mRNA persisted in hepatocytes, the presence of IGF-I
peptide decreased with age and could not be detected after
90 DPF.
Gastro-intestinal tract
IGF-I mRNA and peptide appeared in cells of the intestinal
mucosal epithelium at 5 DPF (Fig. 2a,b). At 9 DPF, they
were also detected in cells of the stomach epithelium.
Virtually all epithelial cells of the gastro-intestinal tract
contained IGF-I mRNA and peptide. IGF-I-immunore-
active material was mainly located in the cell apex
(Fig. 2a,c,d). The largest numbers of mucosal epithelial
cells exhibiting IGF-I mRNA and peptide were found at 13-
29 DPF (Fig. 2c–e, Table 1). Around 17 DPF, additional
IGF-I-containing cells were detected with the typical
appearance of endocrine cells (Fig. 2c). These IGF-I-
immunoreactive cells occurred in all portions of the gastro-
intestinal tract but their distribution and frequency varied
largely among different individuals. The cells persisted
until the adult stage, whereas the presence of IGF-I
immunoreactivity in the cell apex was limited to about 50
DPF (Table 1).
Pancreas
In the exocrine pancreas, the first cells with IGF-I mRNA
were present as early as 4 DPF. Their number increased at
around 6 DPF (Fig. 2f) and persisted at a high level until 18
DPF (Table 1). Thereafter, the number of IGF-I-containing
acinar cells decreased until about 90 DPF and could not be
detected in adults.
Fig. 2 IGF-I immunoreactivity and mRNA in developing tilapia
gastro-intestinal tract and pancreas. a, b At 5 DPF, most mucosal
epithelial cells in the developing intestine show IGF-I immunore-
activity in the apex (a) and also IGF-I mRNA (b) on consecutive
sections. Bar 25 μm. c At 17 DPF, additional IGF-I-containing cells
(arrows) are found with the typical appearance of endocrine cells.
Bar 25 μm. d, e At 29 DPF, numerous cells in the mucosal
epithelium of the stomach are IGF-I-immunoreactive (d) and contain
IGF-I mRNA (e). Bar 40 μm. f At 6 DPF, several endocrine cells in
the islet contain IGF-I mRNA (arrows). Numerous acinar cells of
the surrounding exocrine pancreas (ex, arrows) also exhibit IGF-I
mRNA. Bar 25 μm. g At 76 DPF, no IGF-I immunoreactivity is
observed in the exocrine pancreas but numerous cells in the islets are
IGF-I-immunoreactive. As shown by double immunofluorescence,
these cells constitute a subpopulation different from insulin-
immunoreactive cells (h). Bar 25 μm
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At 6 DPF, some islet cells appeared containing IGF-I
mRNA (Fig. 2f) and peptide. Their number increased until
18 DPF. The IGF-I-containing islets cells did not contain
insulin (Fig. 2g,h).
Kidney
At 8 DPF, IGF-I immunoreactivity (Fig. 3a) and mRNA
appeared in the vast majority of renal vesicles and in the
pronephric ducts. Faint IGF-I immunoreactivity (Fig. 3b)
and mRNA were present in the renal tubules forming
around 13 DPF. In the pronephric ducts, IGF-I immuno-
reactivity was located in the apical cell portion (Fig. 3a,b).
Around 17 DPF, the epithelial cells of the pronephric
urinary ducts (Fig. 3c) contained strong IGF-I immunore-
activity in the cell apex. Furthermore, numerous proximal
tubules exhibited IGF-I mRNA (Fig. 3d) and immunore-
activity (Fig. 3e), whereas most of the distal tubules
showed only faint reactions (Fig. 3e). This distribution
pattern persisted until 25 DPF (Fig. 3f). Later, some
proximal and distal tubules contained IGF-I immunoreac-
tivity (Fig. 3g) and mRNA. In addition, strong IGF
immunoreactivity was present in the apical cell portions of
the collecting ducts (Fig. 3g). The same distribution pattern
was also found in juvenile and adult tilapia (Table 1).
Cartilage
Even at 4-5 DPF, IGF-I mRNA and peptide were present in
cartilage (Table 1). The expression of IGF-I was most
pronounced in growing regions (Fig. 4a,b). Numerous
chondrocytes expressing IGF-I were found in the cartilage
Fig. 3 IGF-I in developing kidney. a At 8 DPF, IGF-I immuno-
reactivity is present in most of the renal vesicles (rv) and in the
pronephric duct (pd). Bar 25 μm. b At 13 DPF, several renal tubules
(rt) contain faint IGF-I immunoreactivity. In the pronephric duct
(pd), IGF-I immunoreactivity is located in the apical cell portion (hk
head kidney). Bar 30 μm. c–e Epithelial cells of the pronephric
urinary ducts (pud) show strong IGF-I immunoreactivity in the apex
at 17 DPF. Numerous proximal (pt) and distal (dt) tubules exhibit
IGF-I mRNA (d) and immunoreactivity (e). Bars 20 μm (c), 30 μm
(d), 20 μm (e). f At 25 DPF, most of the proximal tubules (pt)
contain IGF-I mRNA but no expression is seen in the distal tubules
(dt). Bar 20 μm. g At 29 DPF, some proximal (pt) and distal (dt)
tubules and a collecting duct (cd) show IGF-I immunoreactivity. Bar
15 μm
292
at various locations (Figs. 4c,d,g, 5a, 6a,d) throughout
development. Their number slowly decreased with time
and they were also found in adult life.
IGF-I was also detected by in situ hybridization and
immunohistochemistry in the perichondrium starting at 4
DPF. The expression of IGF-I in the perichondrium was
most pronounced between 6 and 50 DPF (Table 1) and
persisted throughout life at a moderate level.
Muscle
IGF-I mRNA and peptide appeared in skeletal muscle
fibers at 4 DPF (Table 1). Both were present in the
cytoplasm (Fig. 4e,f). The highest expression of IGF-I in
skeletal muscle was between 8 and 29 DPF (Table 1).
Thereafter, it decreased (Fig. 4g) but persisted throughout
development and adult life.
Gills
The production of IGF-I in gills had its onset at 6 DPF
(Fig. 5a; Table 1). From the beginning, both IGF-I mRNA
and peptide occurred in the majority of chloride cells. This
distribution pattern was found throughout development
(Fig. 5b,c) and adult life.
Heart
At 13 DPF, IGF-I was first detected in the developing heart
(Table 1). IGF-I was present both in atrial (Fig. 5d) and
ventricular (Fig. 5e) myocardiocytes. The highest amount
of IGF-I-containing myocardiocytes was present from 19
to 29 DPF. In general, the number of cells showing IGF-I
mRNA was higher than that of cells exhibiting IGF-I
immunoreactivity (Table 1). During late development and
in adults, no IGF-I could be detected in the heart.
Brain
In brain, strong IGF-I mRNA signals were revealed in
numerous neurones of the brain of larvae (Fig. 6a) starting
around 6 DPF (Table 1). Similarly, IGF-I immunoreactivity
was present in the vast majority of neurones (Fig. 6c). In
addition, IGF-I was expressed in spinal (Fig. 6d) and in
developing autonomic ganglia. This overall neuronal
presence of IGF-I persisted until about 29 DPF and slowly
decreased thereafter. In older larvae and adult individuals,
IGF-I mRNA and peptide, although still found at all levels
of brain and spinal cord, were present in some neurones
only. In the older fish, the number of neurones containing
IGF-I mRNA exceeded that of the IGF-I-immunoreactive
neurones. Whereas in most areas of the brain, the
distribution patterns of IGF-I mRNA and peptide varied
largely among the individuals investigated, the Purkinje
cells in the cerebellum always showed IGF-I peptide
(Fig. 6e) and mRNA (Fig. 6f). Starting at 4 DPF, IGF-I
Fig. 4 IGF-I in developing cartilage (a–d) and skeletal muscle
(e–g). a At 10 DPF, most chondrocytes and the perichondrium
(pc) contain IGF-I immunoreactivity. b The expression of IGF-I
mRNA is particularly pronounced in growing regions (large
arrow) at 17 DPF. IGF-I mRNA further occurs in the
perichondrium (pc). Bar 15 μm (a, b). IGF-I immunoreactivity
(c) and mRNA (d) are present in the majority of chondrocytes
of spine and rib cartilage and in skeletal muscle (arrows) at 20
DPF. Bar 30 μm. IGF-I immunoreactivity (e) and mRNA (f) are
found in the cytoplasm of all skeletal muscle fibers at 17 DPF.
Bar 10 μm. g At 50 DPF, numerous muscle fibers still show
IGF-I immunoreactivity (ca cartilage). Bar 50 μm
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immunoreactivity and mRNA were observed in the
meninges (Fig. 6a). The expression of IGF-I persisted at
the initial level until 50 DPF but stayed at a low level
throughout life (Table 1).
Fig. 6 IGF-I in the central and peripheral nervous systems. a, b In
situ hybridization of serial sections of tilapia brain with an IGF-I
antisense probe (a) and an IGF-I sense probe (b) at 20 DPF.
Abundant neurons exhibit IGF-I mRNA (a) whereas no IGF-I
mRNA is located in the negative control (b). IGF-I mRNA also
occurs in the meninges (arrowheads), in chondrocytes of the
cartilage (ca) and in skeletal muscle cells (arrows, m). Bar 40
μm. c IGF-I immunoreactivity is present in numerous central
neurones at 20 DPF. Bar 100 μm. d Several neurones in the
spinal ganglion (SG) exhibit IGF-I immunoreactivity (ca car-
tilage). Bar 20 μm. e, f At 70 DPF, Purkinje cells (arrows) in
the cerebellum contain IGF-I peptide (e) and IGF-I mRNA (f).
Bar 25 μm
Fig. 5 IGF-I immunoreactivity and mRNA in gills (a–c) and
heart (d, e). a At 6 DPF, IGF-I immunoreactivity is present in
numerous chloride cells and also occurs in gill cartilage (ca).
Bar 45 μm. b, c The production of IGF-I is found in most
chloride cells (arrows) in later development as shown for 70
DPF. Bar 20 μm. d, e The presence (arrows) of IGF im-
munoreactivity (d) and mRNA (e) in cardiomyocytes of the
developing heart at 29 DPF. Bar 20 μm
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Pituitary
IGF-I occurred in both portions of the tilapia pituitary but
appeared later than in brain. The first neurosecretory axons
containing IGF-I immunoreactivity (Fig. 7a,c) appeared in
the posterior (neuro-) pituitary around 17 DPF (Table 1).
Their density decreased with age but they were still
detected in adults. No IGF-I mRNA was detected in the
posterior pituitary. IGF-I-immunoreactive neurons oc-
curred in hypothalamus (Fig. 7c). Endocrine cells of the
anterior (adeno-) pituitary first exhibited IGF-I mRNA at
28 DPF (Fig. 7b) followed by IGF-I immunoreactivity at
40 DPF (Fig. 7c). IGF-I immunoreactivity (Fig. 7c) and
mRNA (Fig. 7d) in endocrine cells were present through-
out development and in adults.
Skin
At 5 DPF, IGF-I immunoreactivity appeared in cells of the
epidermis (Fig. 8a). First, the number of epidermal cells
exhibiting IGF peptide (Fig. 8b) and mRNA (Fig. 8c)
increased with age to reach the highest level around 19-29
DPF (Table 1). In older larvae (Fig. 8d,e) and adults, some
superficial epidermal cells (arrows) and occasionally also
cells in the basal epidermis (arrowhead) were IGF-I-
immunoreactive or contained IGF-I mRNA (Fig. 8e).
Discussion
This study has revealed the appearance and distribution of
IGF-I mRNA and peptide during the early development of
the tilapia, O. niloticus. Both IGF-I mRNA and peptide
have been observed in parenchymal cells of all organs
investigated but the onset, intensity and duration of IGF-I
expression differs considerably among the various tissues
and organs.
Both IGF-I mRNA and peptide appear in liver at 4 DPF.
This early onset of IGF-I production in tilapia liver is in
agreement with results obtained in shi drum in which IGF-I
immunoreactivity has been detected in hepatocytes during
the first week post hatching (Radaelli et al. 2003). Because
liver is the main source of endocrine IGF-I, these results
suggest a particular physiological impact of circulating
IGF-I in early development. Although high expression of
Fig. 7 IGF-I immunoreactivity and mRNA in the pituitary as
revealed in two pairs of consecutive sections (a, b and c, d)
processed for immunofluorescence (a, c) and in situ hybridization
(b, d). a, b At 28 DPF, numerous axons in the neuropituitary contain
IGF-I immunoreactivity (a) but no IGF-I mRNA is present (b). In
the adenopituitary, most of the endocrine cells exhibit IGF-I mRNA
(b), whereas they do not show IGF-I immunoreactivity (a). Most
neurons in the hypothalamus (H) exhibit IGF-I mRNA (b). Bar
40 μm. c, d At 40 DPF, both IGF-I immunoreactivity (c) and mRNA
(d) are detectable in endocrine cells of the anterior pituitary. IGF-I-
immunoreactive axons are present in the posterior part. An IGF-I-
immunoreactive neuron (c, arrow) is shown in the hypothalamus.
Bar 70 μm
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IGF-I mRNA has been detected throughout life in tilapia
liver, IGF-I immunoreactivity decreases with age and is
present only until about 70 DPF. In contrast to an earlier
study on sea bream (Funkenstein et al. 1997), an intense
response by in situ hybridization for IGF-I has been
obtained in adult tilapia liver. In spite of the clear
expression of IGF-I mRNA in adult tilapia liver (Schmid
et al. 1999), no IGF-I-immunoreactive hepatocytes have
been identified in adult barramundi (Richardson et
al. 1995) and tilapia (Reinecke et al. 1997; Schmid et
al. 1999). Similarly, in rat liver, IGF-I immunoreactivity
has been localized only after pretreatment with colchicine
(Hansson et al. 1988). Therefore, IGF-I might be released
from fish liver into the circulation immediately after
synthesis, as has previously been presumed in mammals
(Hansson et al. 1988).
High-affinity hepatic-binding sites for growth hormone
(GH) have been identified in the liver of several fish
species, including tilapia (Ng et al. 1992). In accordance,
there is strong evidence that GH stimulates IGF-I expres-
sion in fish liver and its secretion into the circulation (see
Reinecke et al. 2005). Injection or oral administration of
GH significantly enhances the IGF-I mRNA level in the
liver of numerous species (e.g. Duan et al. 1993; Duguay et
al. 1994, 1996; Moriyama 1995; Shamblott et al. 1995;
Shepherd et al. 1997; Vong et al. 2003; Biga et al. 2004).
The GH-induced increase in liver IGF-I mRNA expression
is accompanied by an increase in the level of circulating
IGF-I (Funkenstein et al. 1989; Niu et al. 1993; Moriyama
et al. 2000). In addition to these in vivo studies, some in
vitro investigations have also demonstrated the stimulating
effect of GH on liver IGF-I mRNA expression, i.e. on
primary cultured hepatocytes of salmonids (Duan et
al. 1993; Shamblott et al. 1995; Pierce et al. 2005) and
tilapia (Schmid et al. 2000). In rainbow trout, GH mRNA
has been detected in early stage embryos (Yang et al. 1999).
Thus, the production and release of liver IGF-I during
tilapia early development may be under the control of GH.
The early onset of the production of IGF-I in tilapia
gastro-intestinal tract, i.e. at 5 DPF in intestine and at 9
DPF in stomach, supports the results of earlier studies. In
the intestinal epithelium of turbot (Berwert et al. 1995) and
shi drum (Radaelli et al. 2003), the first IGF-I-immunore-
active cells can be found as early as the first week post
hatching. Furthermore, IGF-1R appears in the second week
post hatching in shi drum gut (Radaelli et al. 2003). The
number of IGF-I-producing cells in the developing bony
fish gastro-intestinal tract by far exceeds that in the adult
because, during ontogeny, almost all epithelial cells
throughout the gastro-intestinal tract exhibit IGF-I
mRNA and peptide. The IGF-I-immunoreactive material
is mainly located in the cell apex as has also been reported
in shi drum (Radaelli et al. 2003), possibly suggesting
release into the lumen. Around 17 DPF, additional
infrequent IGF-I-containing cells appear in the mucosal
epithelium; these cells have the typical appearance of
endocrine cells as characterized for adult fish (Reinecke et
al. 1997; Koppang et al. 1998). The distribution of these
IGF-I-immunoreactive cells in the various portions of the
adult gastro-intestinal tract and their frequency vary largely
among different individuals, as previously reported in
turbot (Berwert et al. 1995) and Atlantic salmon (Koppang
et al. 1998).
Although the early and overall appearance of IGF-I and
its receptor strongly suggests a particular physiological
impact of IGF-I in the developing gastro-intestinal tract, we
can only hypothesize on the physiological meaning of
intestinal IGF-I in fish. IGF-I secreted from the IGF-I-
immunoreactive epithelial cells may exert mitogenic
functions by acting on neighbouring epithelial cells. This
Fig. 8 IGF-I immunoreactivity and mRNA in the skin. a At 5 DPF,
several cells in the epidermis contain IGF-I immunoreactivity. In
the dermis, a possible dendritic cell also shows IGF-I immunore-
activity (arrow). Bar 40 μm. b, c At 25 DPF, numerous cells in all
epidermal layers exhibit IGF-I peptide (b) and mRNA (c). Bar
30 μm. d, e Frequent superficial epidermal cells (arrows) and
infrequent basal epidermal cells (arrowheads) exhibit IGF-I
immunoreactivity (d) and mRNA (e) at 36 DPF. Bars 50 μm (d),
40 μm (e)
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hypothesis is supported by results obtained in mammals. In
pig, the amounts of intestinal IGF-I immunoreactivity and
of the IGF-1R can be correlated with villous growth and
maturation (Schober et al. 1990) and, in adult rat, IGF-I
potently stimulates crypt cell proliferation and villus cell
density (Steeb et al. 1994). The potential proliferative
action of intestinal IGF-I during development and adult life
may be regulated by GH, which markedly increases the
amount of intestinal IGF-I mRNA in juvenile common carp
(Vong et al. 2003) and adult rainbow trout (Biga et
al. 2004).
In juvenile and adult bony fish, IGF-I released from the
infrequent IGF-I-immunoreactive mucosal epithelial cells
may exert paracrine effects in response to altering local
demands, such as repair. In agreement with this hypothesis,
the therapeutical potential of IGF-I has been discerned for
numerous acute human bowel disorders resulting in
accelerated intestinal repair and epithelial regrowth
(Howarth 2003). Because, in addition to gill and kidney,
the intestinal tract exerts important osmoregulatory func-
tions in fish, intestinal IGF-I may also be involved in
osmoregulation (Koppang et al. 1998; Reinecke and
Collet 1998). This hypothesis is supported by experiments
in brown trout suggesting that IGF-I plays a role in the
regulation of intestinal Na+,K+-ATPase activity (Seidelin
and Madsen 1999).
IGF-I immunoreactivity has been localized in cells of the
exocrine parenchyma of shi drum and seabream larvae
(Funkenstein et al. 1997; Perrot et al. 1999; Radaelli et
al. 2003); this is supported by the results of the present
study. As IGF-I production in pancreas is stimulated by GH
in rat (Jevdjovic et al. 2004), IGF-I in fish pancreas may
also be under the control of GH, although no results have
been presented to date on the potential regulation of IGF-I
in the exocrine pancreas.
To date, indications for the presence of IGF-I in the
endocrine pancreas have only been obtained by immuno-
histochemical studies. These have shown that IGF-I
immunoreactivity occurs in islet cells of several bony
fish species (Reinecke et al. 1993, 1997; Berwert et
al. 1995; Richardson et al. 1995). The present study
provides the additional information that IGF-I mRNA is
also present in islet cells. This is supported by molecular
biological studies that have shown IGF-I mRNA expres-
sion in principal islets of the salmon O. gorbusha
(Plisetskaya et al. 1993) and of Cottus scorpius (Loffing-
Cueni et al. 1998). Islet IGF-I appears at 6 DPF in tilapia
(this study) and day 10 post hatching in turbot (Berwert et
al. 1995) suggesting a significant physiological role for
islet-derived IGF-I during larval development. In both
species, from the onset of its expression, IGF-I occurs in
non-insulin cells. This observation is in agreement with
studies on adult teleosts, such as eel, tilapia, goldfish,
turbot and common carp (Reinecke et al. 1993, 1997;
Berwert et al. 1995).
On the one hand, islet-derived IGF-I may be involved in
the paracrine regulation of insulin secretion from the β-
cells, although the evidence in mammals is conflicting
(Leahy and Vandekerkhove 1990; Van Schravendijk et
al. 1990; Jevdjovic et al. 2004). On the other hand, some
studies suggest that islet-derived IGF-I may act as an
endocrine hormone. Hypophysectomy does not influence
the amount of sulphation activity in eel pancreas (Duan and
Hirano 1992) suggesting that islet IGF-I is not regulated by
GH. In goby, islectomy leads to a decrease in 35SO4-
incorporation in cartilage (Bern et al. 1991) but hepatic
GH binding is unchanged (Kelley et al. 1993). The
observed effects may have been augmented by insulin
(Plisetskaya 1998). However, in addition to the GH-
dependent liver IGF-I system, islet-derived IGF-I may
constitute a further endocrine GH-independent IGF-I
system involved in the regulation of fish growth.
No information is available on IGF-I in developing fish
kidney. In adult bony fish, however, epithelial cells mainly
of the proximal tubules have been reported as sites of IGF-I
production in tilapia (Reinecke et al. 1997), as has similarly
been described in adult mammals (see Reinecke and
Collet 1998). In tilapia, IGF-I occurs in renal vesicles even
at early stages of development, i.e. at 5 DPF. Later, it is
present in proximal and distal tubles and in collecting and
urinary ducts. Whereas IGF-I in the tubular sytem is
detected throughout the cytoplasm, it occurs only in the
apical cell part in the ducts possibly suggesting the release
of IGF-I into the lumen. Apart from the gills, the kidney is a
major osmoregulatory organ in fish but the evidence for the
potential participation of renal IGF-I in osmoregulation is
conflicting. In rainbow trout, transfer to seawater has been
reported to increase the IGF-I mRNA level in kidney
(Sakamoto and Hirano 1993). In contrast, the same
treatment does not affect the Na+,K+-ATPase gene level
and activity in brown trout (Madsen et al. 1995) or the renal
IGF-I mRNA level in the four-spine sculpin, Cottus kazika
(Inoue et al. 2003). Thus, at present, we can only speculate
about the physiological role of IGF-I in bony fish kidney.
In addition to its possible role in osmoregulation, renal
IGF-I may be involved in several other parameters of
kidney function, such as the stimulation of kidney growth
and differentiation, renal blood flow, glomerular filtration
rate and sodium absorption, as is likely in mammals
(Hirschberg 1996).
In O. niloticus, IGF-I also appears early in tissues that
are highly involved in growth, such as cartilage and
skeletal muscle. At 4 DPF, IGF-I mRNA and peptide are
present in the chondrocytes of cartilage at various
locations. Similarly, in shi drum, IGF-I immunoreactivity
has been observed in cartilage at day 11 post hatching
(Radaelli et al. 2003). The expression of IGF-I in tilapia is
most pronounced in growing regions. The number of IGF-
I-containing chondrocytes is higher during development
than in adult life, thus underlining the physiological
impact of local IGF-I during cartilage growth. Although
the GH/liver IGF-I axis is involved in the regulation of
fish growth as an endocrine system (Duan 1998; Reinecke
et al. 2005), an influence of GH on growth via local auto/
paracrine IGF-I, as indicated by the present results, is also
likely. An early study on eel has determined that the
stimulatory effect of GH on sulphate incorporation into
cartilage is mediated by an IGF-like plasma factor (Duan
297
and Inui 1990). In agreement, the injection of GH into
coho salmon cartilage stimulates sulphate and thymidine
incorporation (McCormick et al. 1992; Tsai et al. 1994).
Thus, GH may have increased both uptakes via the
stimulation of local IGF-I, because IGF-I peptide and
mRNA have been shown in chondrocytes of developing
(Perrot et al. 1999; Radaelli et al. 2003; this study) and
adult (Funkenstein et al. 1997; Reinecke et al. 1997) bony
fish. The GH-dependent growth promoting effects of IGF-
I on cartilage may therefore be exerted not only via the
endocrine route, but also in an autocrine/paracrine manner
by IGF-I released from local chondrocytes, as has been
shown in rat (Reinecke et al. 2000).
In contrast to the skeletal muscle of young shi drum
larvae (Radaelli et al. 2003) in which no IGF-I immuno-
reactivity has been detected, the onset of IGF-I production
in tilapia skeletal muscle occurs at 4 DPF, with IGF-I
showing a maximum around 10-29 DPF, decreasing
afterwards but persisting throughout life. In agreement
with an auto/paracrine function of muscle IGF-I, IGF-I
receptor number and binding in trout skeletal muscle are
highest at 5 weeks and both parameters decrease with age
(Mendez et al. 2001). Furthermore, a parallel age-related
decline has been found for tyrosine kinase activity for IGF-
1R (Mendez et al. 2001). In rainbow trout muscle in vitro,
IGF-I has been shown to be highly effective in stimulating
glucose and alanine uptake into myosatellite cells, whereby
the degree of stimulation changes when cells differentiate
to myotubes (Castillo et al. 2004). These and the present
results showing that IGF-I in skeletal muscle appears as
early as 4 DPF and decreases with age indicate a key role
for IGF-I in muscle development. IGF-I may be associated
in later life with metabolism and repair mechanisms. In
adult rainbow trout, the expression of IGF-I in skeletal
muscle is stimulated by GH (Biga et al. 2005). Thus, GH
may also regulate IGF-I production in larval musle.
Endocrine (liver-derived) IGF-I seems to have a
physiological impact in smoltification. In mummichog
(Fundulus heteroclitus; Mancera and McCormick 1998)
and trout (Seidelin et al. 1999), IGF-I improves adaptation
to seawater in a dose-dependent manner. The osmoregu-
latory effects of IGF-I seem to be exerted directly because,
in preparations of Coho salmon gills in vitro, IGF-I
stimulates Na+,K+-ATPase (Madsen and Bern 1993).
Hypophysectomy in tilapia lowers the levels of gill Na+,
K+-ATPase when compared with that of sham-operated
controls (Shepherd et al. 1997) indicating an involvement
of the GH/liver IGF-I axis. In agreement, in a study on
Cottus kazika, the level of liver IGF-I mRNA has been
shown to be significantly higher in individuals reared in
seawater than in those reared in freshwater (Inoue et
al. 2003). In sharp contrast, a study on Coho salmon has
demonstrated that IGF-I mRNA is not significantly altered
during seawater adaptation in liver but markedly increases
in gills (Sakamoto and Hirano 1993). The chloride cells of
filament epithelium have been shown not only to express
Na+,K+-ATPase in trout (McCormick 1996), but also IGF-
I in tilapia (this study), in shi drum larvae (Radaelli et
al. 2003) and in adult tilapia (Reinecke et al. 1997). GH
receptors have been detected in tilapia gills (Fryer 1979)
and GH treatment increases IGF-I mRNA in gills of
salmonids and carp (Vong et al. 2003; Biga et al. 2004).
Thus, in addition to circulating IGF-I, GH-regulated local
autocrine/paracrine IGF-I in the chloride cells seems to
participate in the regulation of plasma osmolality and gill
Na+,K+-ATPase activity. Because the expression of IGF-I
in tilapia gill chloride cells has been detected even around
6-7 DPF, IGF-I may exert additional functions, such as
influencing the growth and maintenance of the filament
epithelium.
In shi drum heart, IGF-I immunoreactivity has been
detected in 15-day larvae (Radaelli et al 2003). Likewise,
IGF-I mRNA and peptide appear at 13 DPF in tilapia. The
expression of IGF-I in cardiomyocytes is clearly detectable
until 70 DPF but is absent from later stages and adults
indicating a particular physiological impact of IGF-I during
heart development and growth. In correlation, a significant
increase in IGF-1R mRNA levels (Gutiérrez et al. 1995)
has been observed in the rapidly growing juvenile trout
heart (Greene and Chen 1999). In fish heart, local IGF-I
may be even more important than circulating IGF-I. In
rainbow trout heart IGF-1R mRNA levels decrease after
application of GH (Biga et al. 2004) and the number of
IGF-I receptors is inversely related to the concentration of
circulating IGF-I (Baños et al. 1997; Moon et al. 1996).
Screening studies have identified the potential sites of
IGF-I synthesis in the brains of barramundi, tilapia and sea
bream. IGF-I-immunoreactive neurones are present in adult
barramundi brainstem (Richardson et al. 1995) and at all
levels of adult tilapia brain (Reinecke et al. 1997).
Correspondingly, IGF-I mRNA signals have been de-
scribed throughout the brain of developing sea bream
(Funkenstein et al. 1997). The functional impact of IGF-I in
brain is indicated by the presence of IGF-1R in adult carp
and trout brain (Leibush et al. 1996) and by the appearance
of IGF-1R immunoreactivity in the developing brain of shi
drum as early as hatching (Radaelli et al. 2003). In contrast
to IGF-II (Caelers et al. 2003), the exact distribution of
IGF-I gene expression in fish brain is unknown. The IGF-I-
immunoreactive neurones in barramundi and tilapia are
sparsely scattered and their distribution exhibits pro-
nounced inter-individual differences. In juvenile (this
study) and adult tilapia (Reinecke et al. 1997) and adult
daddy sculpin (Loffing-Cueni et al. 1998) brain, only IGF-
I-producing Purkinje cells in cerebellum are constantly
present. In agreement with the potential autocrine/paracrine
action of neuronal IGF-I in adult brown trout, Salmo trutta,
IGF-I binding in the brain is highest in the cerebellum
(Smith et al. 2005). The pronounced inter-individual
variations of IGF-I-producing neurones in adult fish brain
make a neurotransmitter or -modulator function of IGF-I
unlikely. Rather, neuronal IGF-I may support the survival
of neurones and glia cells, as is also likely for mammals
(Cheng et al. 2001). During development, IGF-I may
stimulate neurogenesis, dendritic growth and synaptogen-
esis in an autocrine/paracrine manner, as has been shown in
mammals (e.g. Zhou et al. 1999; Niblock et al. 2000;
Kakizawa et al. 2003). This hypothesis is supported by the
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observation that, in early developing tilapia larvae, most
neurones express IGF-I mRNA and that the number of
neurones containing IGF-I mRNA decreases with age.
Whether the assumed actions of IGF-I are exerted under the
control of GH is unclear at present, since GH significantly
increases brain IGF-I mRNA in rainbow trout (Biga et
al. 2004), whereas no effect has been reported in common
carp (Vong et al. 2003).
The present study is the first to show that IGF-I occurs in
the bony fish pituitary. IGF-I has been observed in both the
neuro- and adenopituitary. In the posterior part, neurose-
cretory axons containing IGF-I immunoreactivity appear
around 17 DPF, whereas no IGF-I mRNA is detected at this
stage. The likely source of IGF-I in the neuropituitary is the
neuronal perikarya that lie within the hypothalamus and
that exhibit IGF-I immunoreactivity. In the adenopituitary,
IGF-I mRNA is first detected at 20 DPF. IGF-I immuno-
reactivity and mRNA in endocrine cells are present
throughout development. To date, IGF-I immunoreactivity
has only been localized in the anterior pituitary in the frog
Xenopus laevis in which it occurs in co-existence with
prolactin (David et al. 2000). Because IGF-I-binding sites
have also been found in X. laevis anterior pituitary, IGF-I
from the prolactin cells has been postulated to regulate GH
in a paracrine manner (David et al. 2000). Whether this
hypothesis also applies to bony fish remains to be clarified,
as does the type of endocrine cells producing IGF-I.
At 5 DPF, IGF-I has been detected in cells of the
epidermis of tilapia. The number of IGF-I-producing
epidermal cells first increases with age, reaching its highest
level around 19-29 DPF. In older larvae and adults, some
superficial and basal epidermal cells exhibit IGF-I immu-
noreactivity or IGF-I mRNA. In developing skin of shi
drum, IGF-1R immunoreactivity is detectable even at
hatching (Radaelli et al. 2003). The early appearance of
both IGF-I and its receptor suggests an important auto/
paracrine function of IGF-I in skin development. Because
some IGF-I producing cells still occur in the basal and
superficial layers in juvenile and adult tilapia and as high
levels of IGF receptor mRNA have been found in adult
gilthead seabream skin (Perrot et al. 1999), local IGF-I in
fish skin might play a role in later life. Skin IGF-I might be
involved in repair mechanisms and wound healing, as has
been proposed in mammals (Edmondson et al. 2003).
In summary, the expression of IGF-I is more pronounced
during ontogeny than in juvenile and adult life in the
parenchymal cells of most of the organs investigated, such
as epithelial cells of the gastro-intestinal tract, acinar cells
of the exocrine pancreas, skeletal muscle cells, cardiomyo-
cytes, renal tubular cells, neurones of the central and
peripheral nervous system and skin cells. These results
suggest a high functional impact of local IGF-I in early fish
growth, metabolism and organogenesis by auto/paracrine
means of regulation. Whether IGF-I expression in the early
development of fish is regulated by GH remains to be
clarified (Perrot et al. 1999; Deane et al. 2003), although
low levels of GH mRNA have been detected as early as
gastrulation in rainbow trout and intermediate amounts of
GH mRNA have been observed in early cleavage-stage
embryos (Yang et al. 1999).
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